blog

New iPhone App

Mon, 13 Feb 2012 17:54:31 +1100

The app will be free and based on research carried out at QCGC in collaboration with the Cleveland Clinic. It suggests that the risk and the localisation of recurrence can be predicted to some extent. We identified eight (8) factors that are routinely available to gynaecological oncologists: Patients age at diagnosis, FIGO stage, histological cell type, Grade, Lymph vascular space invasion, depth of myometrial invasion, peritoneal cytology and maximum tumour size. The app calculates the risk of local (vagina and pelvis) and distant (outside the pelvis) recurrence.

At the Queensland Centre for Gynaecological Cancer we are in the final stages of developing a new iPhone app (Uterine Cancer Recurrence Prediction Calculator) to estimate the risk of recurrence after surgery for uterine cancer.

The risk calculator is based on data collected from 2,097 patients who underwent surgery for stage 1 to 3 uterine cancer in Queensland (Australia) and on statistical support from the Cleveland Clinic, Ohio, USA.

Information for patients: Please contact your clinician to obtain the information required for the app and to discuss the clinical significance of the findings. The risk calculator does not represent or replace a medical consultation. This app was developed with the greatest scientific carefulness but the developers make no warranties regarding the accuracy or usefulness of any information provided in the risk calculator. The app may be updated from time to time as new evidence emerges.

Battle Against Ovarian Cancer

Mon, 13 Feb 2012 17:42:18 +1100

Queensland Reds vs. Firebirds Queensland - a beach volleyball competition. The Queensland Reds and the Firebirds met to play beach volleyball on 29 January 2012. The event was hosted by Natalie Cook, Olympic champion in Beach Volleyball, 2000. More than $80,000 will go to Gynaecological Cancer research and advance diagnosis and treatment of patients affected by gynaecological cancer.

For more information on the event visit the website at www.battleagainstovariancancer.org

Australian Ovarian Cancer Vaccine Trial

Mon, 16 May 2011 05:30:01 +1000

An ovarian cancer vaccine represents a novel approach to treatment of ovarian cancer in Australia. Only 10 to 15 sites world-wide will be able to participate in this study and Greenslopes Private Hospital is privileged to take part as one of only two hospitals in Australia. A total of 60 patients will be entered into the study world-wide.

Patients who are in full remission after first or second line chemotherapy for ovarian cancer are eligible. Patients need to have completed chemotherapy and after chemotherapy must not have any evidence of tumour as confirmed on clinical examination, CT scan and tumour marker tests. Patients need to be entered into the study at a maximum of 12 weeks after the completion of their chemotherapy. Patients will be randomly selected to receive the vaccine with half of patients receiving the vaccine. A total of 10 vaccine administrations will be given over almost a year’s time. Each vaccination will consist of some needle pricks into the skin on different parts of the body. Extensive clinical, laboratory and safety checks are built in as a matter of routine as long as patients are on study. The vaccine is tested for safety (how safe is it?) and efficacy (how well does it work?).

Patients do not need to have completed their previous treatment at Greenslopes Private Hospital. If you are interested pls email me.